Find Me Cure: Maya Zlatanova on the Problem with a Perfect Product

<p> </p> <p> </p> <p>Maya Zlatanova is a healthcare technology entrepreneur and the co-founder and CEO of FindMeCure, as well as a clinical research expert with over fifteen years of experience in areas including clinical research regulations and patient recruitment. Maya, who lives in Bulgaria, is also an industry speaker and has presented at several summits and forums, including Scope Summit, Logipharma, Clinical Trial Innovations, Patient Engagement Forum, and GIANT Health. Additionally, Maya is a board member for the Alliance for Clinical Research Excellence and Safety.</p> <p> </p> <p>Today, Maya joins me to discuss her brand FindMeCure and how her sister’s health journey played a role in her desire to launch the platform. She shares the need she set out to solve and why she believes you should follow your passions and desires to make meaningful contributions. Maya also provides insights into clinical trials, the importance of perspective as you develop a product, and why you need to be disciplined with your work when juggling your entrepreneurial ventures with having a family.</p> <p> </p> <p> </p> <p> </p> <p>“Focus on the journey, not the destination.” - Maya Zlatanova</p> <p align="center"> </p> <p align="center"> </p> <p> </p> <p><strong>Today on When She Founded:</strong></p> <p> </p> <ul> <li>How Bulgaria is handling the COVID-19 pandemic and the most significant concerns the country has</li> <li>FindMeCure’s role in combatting the coronavirus pandemic</li> <li>Where Maya’s inspiration for founding FindMeCure came from and how she met her co-founders</li> <li>What remote clinical trials are, their purpose, and what they can look like</li> <li>The process of developing and launching a product and why it is crucial to get others on board</li> <li>The fear of feedback and the power of pushing through vulnerability to gain insight</li> <li>FindMeCure’s fundamental principles and how the brand’s hiring decisions relate to these principles</li> <li>Maya’s definition of eligibility criteria and why these par